查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1927704

全球内分泌功能诊断市场：依检测类型、技术、应用、国家及地区划分－产业分析、市场规模、份额及2025年至2032年未来预测

Endocrine Function Diagnostics Market, Report By Test Type, By Technology, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 310 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2024 年，内分泌功能诊断市场规模将达到 131.201 亿美元，从 2025 年到 2032 年，复合年增长率将达到 7.97%。

由于荷尔蒙失调盛行率上升、糖尿病和甲状腺疾病发病率增加，以及对早期精准诊断解决方案的需求不断增长，全球内分泌功能诊断市场正经历稳定成长。内分泌诊断在评估荷尔蒙水平和腺体功能方面发挥关键作用，有助于疾病诊断、治疗方案製定和长期监测。免疫检测、质谱和自动化分析仪等技术的进步，以及诊断基础设施的不断完善，正在推动已开发经济体和新兴经济体的市场成长。

内分泌功能诊断市场动态

荷尔蒙和代谢紊乱症的盛行率不断上升

糖尿病、甲状腺疾病、肾上腺功能不全和生殖激素失衡等疾病在全球日益加重，是推动内分泌功能诊断需求成长的主要因素，因为有效的疾病管理需要定期进行荷尔蒙检测。人们对预防保健和疾病早期发现的认识不断提高，进一步加速了检测的普及。同时，自动化诊断平台、高灵敏度检测方法和携带式检测解决方案的进步，使得检测更加便捷，结果也更加快速。例如，Eli Health 于 2025 年 1 月推出了 Hormometer，这是一款基于唾液的荷尔蒙分析仪，可连接智慧型手机，实现携带式诊断检测。该平台将行动装置变成个人荷尔蒙分析仪，最初测量皮质醇和黄体素水平，并在大约 20 分钟内提供结果。这标誌着内分泌诊断正朝着去中心化、使用者友善型的方向发展。

内分泌功能诊断市场：細項分析

全球内分泌功能诊断市场按测试类型、技术、应用和地区进行细分。

依检测类型划分，市场可分为甲状腺功能检测、糖尿病检测、肾上腺功能检测、生殖激素检测及其他检测。由于甲状腺疾病和糖尿病在全球范围内的高发生率，这两种检测占据了较大的市场份额。文明病的日益增加以及人们对早期诊断意识提升，进一步扩大了对相关检测的需求。此外，这些检测通常纳入预防性健康检查，也为其提供了较大的市场份额。

依技术划分，此方法可分为免疫检测、串联式质谱质谱（LC-MS/MS）、酵素免疫分析法和其他方法。免疫检测因其应用广泛、灵敏度高且易于自动化，在该领域占据主导地位。其成本效益高、检体通量大，使其适用于常规临床应用。技术的不断进步和标准化试剂盒的普及进一步推动了该领域的发展。

根据应用领域，市场可细分为医院、诊断检查室、研究实验室和其他机构。由于检测量不断增长和检测设施集中化，诊断检查室占据了主要市场份额。诊断连锁机构的扩张和对外包检测服务需求的成长也促进了其市场主导地位。

内分泌功能诊断市场—区域分析

北美在内分泌功能诊断市场占据领先地位，这得益于其先进的医疗基础设施、对荷尔蒙失调的高度重视以及对自动化诊断技术的积极应用。欧洲紧随其后，这主要得益于其完善的检测网路和预防性筛检计画。亚太地区预计将成为成长最快的市场，这主要归功于医疗支出不断增长、糖尿病和甲状腺疾病患病率上升，以及中国和印度等国家诊断能力的不断提升。拉丁美洲以及中东和非洲地区也呈现稳定成长，这得益于医疗服务可近性的提高和诊断技术的现代化。

内分泌功能诊断市场—国家分析

美国凭藉庞大的检测量、有利的报销政策以及众多成熟的诊断公司推动的创新和效率，在内分泌功能诊断市场占据主导地位。这种健全的医疗保健环境促进了先进诊断技术的广泛应用，确保了内分泌疾病的及时发现和治疗。在欧洲，德国、英国和法国的主要企业在强大的公共医疗保健体系和积极的早期疾病筛检措施的支持下，为市场成长做出了显着贡献，这些措施促进了预防性医疗。此外，亚太地区，特别是中国和印度，由于庞大的患者群体和人们对内分泌疾病日益增长的认识，正在崛起为一个快速增长的市场。这些国家医院和实验室的快速扩张进一步提高了诊断服务的可近性和效率。随着这些地区医疗保健系统的不断发展，预计内分泌功能诊断的整体环境将得到改善，从而提高患者的治疗效果和医疗品质。

目录

第一章 内分泌功能诊断市场概述

  • 分析范围
  • 市场估算期

第二章执行摘要

  • 市场区隔
  • 竞争考察

第三章：内分泌功能诊断的主要市场趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 未来市场趋势

第四章 内分泌功能诊断市场：产业分析

  • PEST分析
  • 波特五力分析
  • 市场成长展望：概览
  • 管理体制分析

第五章 内分泌诊断市场：地缘政治紧张局势加剧的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章 内分泌功能诊断市场概况

  • 内分泌功能诊断市占率分析（2024 年）
  • 主要製造商的细分数据
    • 对现有公司的分析
    • 新兴企业分析

第七章 内分泌功能诊断市场（依检测类型划分）

  • 概述
    • 细分市场占有率分析：依测试类型
    • 甲状腺功能检查
    • 糖尿病检测
    • 肾上腺功能检查
    • 生殖荷尔蒙检测
    • 其他的

第八章 内分泌功能诊断市场（依技术划分）

  • 概述
    • 细分市场占有率分析：依技术划分
    • 免疫检测
    • 串联式质谱质谱（LC-MS/MS）
    • 酵素连结免疫检测
    • 其他的

第九章 内分泌功能诊断市场（依应用领域划分）

  • 概述
    • 细分市场占有率分析：按应用
    • 医院
    • 诊断检查室
    • 研究所
    • 其他的

第十章 内分泌功能诊断市场（依地区划分）

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 其他的
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 其他的
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他的
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他的

第十一章 主要供应商分析－内分泌功能诊断产业

  • 竞争对手仪錶板
    • 竞争基准
    • 竞争定位
  • 公司简介
    • Roche Diagnostics
    • Siemens Healthineers
    • Danaher Corporation
    • Thermo Fisher Scientific
    • bioMerieux
    • Sysmex Corporation
    • DiaSorin SpA
    • Mindray Medical International
    • Ortho Clinical Diagnostics

第十二章：分析师视角360度分析

简介目录
Product Code: ANV5960

The Endocrine Function Diagnostics Market size was valued at US$13,120.10 Million in 2024, expanding at a CAGR of 7.97% from 2025 to 2032.

The global endocrine function diagnostics market is witnessing steady growth due to the rising prevalence of hormonal disorders, increasing incidence of diabetes and thyroid diseases, and growing demand for early and accurate diagnostic solutions. Endocrine diagnostics play a critical role in assessing hormone levels and gland function, supporting disease diagnosis, treatment planning, and long-term monitoring. Technological advancements in immunoassays, mass spectrometry, and automated analysers, along with expanding diagnostic infrastructure, are supporting market growth across developed and emerging economies.

Endocrine Function Diagnostics Market- Market Dynamics

Rising prevalence of hormonal and metabolic disorders

The increasing global burden of diabetes, thyroid disorders, adrenal dysfunction, and reproductive hormone imbalances is a major driver fueling demand for endocrine function diagnostics, as these conditions require routine hormone testing for effective disease management. Growing awareness regarding preventive healthcare and early disease detection is further accelerating test adoption. In parallel, advancements in automated diagnostic platforms, high-sensitivity assays, and portable testing solutions are improving accessibility and turnaround time. For instance, in January 2025, Eli Health launched Hormometer, a saliva-based hormone analysis device that integrates with smartphones to enable portable diagnostic testing. The platform transforms mobile devices into personal hormone analysers and initially measures cortisol and progesterone, with results delivered in approximately 20 minutes, highlighting the growing shift toward decentralised and user-friendly endocrine diagnostics.

Endocrine Function Diagnostics Market- Segmentation Analysis:

The Global Endocrine Function Diagnostics Market is segmented on the basis of Test Type, Technology, Application, and Region.

Based on Test Type, the market is categorised into Thyroid Function Tests, Diabetes Tests, Adrenal Function Tests, Reproductive Hormone Tests, and Others. Thyroid and diabetes testing account for a significant share due to high disease prevalence worldwide. The growing incidence of lifestyle-related disorders and increased awareness of early diagnosis further drive testing demand. Additionally, these tests are routinely included in preventive health check-ups, supporting their large market share.

Based on Technology, the market is categorised into Immunoassays, Tandem Mass Spectrometry (LC-MS/MS), Enzyme-linked Assays, and Others. Immunoassays dominate the segment owing to their wide adoption, high sensitivity, and automation compatibility. Their cost-effectiveness and ability to process large sample volumes make them suitable for routine clinical use. Continuous technological advancements and the availability of standardised kits further strengthen this segment.

Based on the application, the market is categorised into Hospitals, Diagnostic Laboratories, Research Institutes, and Others. Diagnostic laboratories hold a major share due to increasing test volumes and centralised testing facilities. The expansion of diagnostic chains and growing preference for outsourced laboratory services also contribute to their market dominance.

Endocrine Function Diagnostics Market- Geographical Insights

North America leads the endocrine function diagnostics market, supported by advanced healthcare infrastructure, high awareness of hormonal disorders, and strong adoption of automated diagnostic technologies. Europe follows closely, driven by established laboratory networks and preventive screening programs. The Asia-Pacific region is expected to witness the fastest growth due to increasing healthcare expenditure, rising diabetes and thyroid disease prevalence, and expanding diagnostic capacity in countries such as China and India. Latin America and the Middle East & Africa are experiencing steady growth supported by improving healthcare access and diagnostic modernisation.

Endocrine Function Diagnostics Market- Country Insights

The United States dominates the endocrine function diagnostics market, primarily due to its high testing volumes, advantageous reimbursement policies, and the presence of established diagnostic companies that drive innovation and efficiency. This robust healthcare environment facilitates widespread access to advanced diagnostic technologies, ensuring timely detection and management of endocrine disorders. In Europe, key players from Germany, the UK, and France significantly contribute to market growth, bolstered by strong public healthcare systems and proactive early disease screening initiatives that promote preventive care. Additionally, the Asia-Pacific region, particularly China and India, is emerging as a high-growth market, fueled by large patient populations and increasing awareness of endocrine disorders. The rapid expansion of hospital and laboratory infrastructure in these countries further supports the accessibility and availability of diagnostic services. As healthcare systems in these regions evolve, they are likely to enhance the overall landscape of endocrine function diagnostics, improving patient outcomes and quality of care.

Endocrine Function Diagnostics Market- Competitive Landscape:

The endocrine function diagnostics market is moderately competitive, characterised by several global and regional players, including Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, bioMerieux, Sysmex Corporation, DiaSorin S.p.A., Mindray Medical International, and Ortho Clinical Diagnostics. These companies are focusing on assay innovation, automation, and expanding their test portfolios to meet healthcare demands. Significant investments are being made in high-throughput platforms, advanced immunoassays, and integrated diagnostic solutions, which enhance accuracy and workflow efficiency in laboratories. Furthermore, strategic collaborations and product launches are pivotal in reinforcing market positions. Geographic expansion remains a crucial strategy, allowing participants to tap into new markets and improve accessibility to endocrine diagnostics, for instance, in September 2024, Trinity Biotech acquired Metabolomics Diagnostics to bolster its maternal health portfolio. The acquisition provides access to deep-tech mass spectrometry and machine learning tools. This expertise supports the development of PrePsia, an early-stage preeclampsia risk test. The move marks a strategic expansion into advanced, biomarker-based diagnostic solutions. The dynamic landscape reflects a commitment to technological advancements and increased patient care quality, essential for effective monitoring and management of endocrine disorders across diverse healthcare settings.

Recent Developments:

In January 2025, Eli Health launched Hormometer, a device for saliva-based hormone analysis. The system uses smartphone technology to perform portable diagnostic testing. By integrating with mobile devices, it turns smartphones into personal analysers.

In April 2023, Eli Health raised USD 3.6 million to advance saliva-based hormone monitoring technology. The company initially focuses on improving care for menopause, fertility, and general health. Long-term plans include expansion into contraception and endocrine disease management. This growth follows the completion of critical clinical trials and regulatory requirements.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ENDOCRINE FUNCTION DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Roche Diagnostics
  • Siemens Healthineers
  • Danaher Corporation
  • Thermo Fisher Scientific
  • bioMerieux
  • Sysmex Corporation
  • DiaSorin S.p.A.
  • Mindray Medical International
  • Ortho Clinical Diagnostics

GLOBAL ENDOCRINE FUNCTION DIAGNOSTICS MARKET, BY TEST TYPE - MARKET ANALYSIS, 2019 - 2032

  • Thyroid Function Tests
  • Diabetes Tests
  • Adrenal Function Tests
  • Reproductive Hormone Tests
  • Others

GLOBAL ENDOCRINE FUNCTION DIAGNOSTICS MARKET, BY TECHNOLOGY ANALYSIS, 2019 - 2032

  • Immunoassays
  • Tandem Mass Spectrometry (LC-MS/MS)
  • Enzyme-linked Assays
  • Others

GLOBAL ENDOCRINE FUNCTION DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes
  • Others

GLOBAL ENDOCRINE FUNCTION DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Endocrine Function Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Endocrine Function Diagnostics Market Snippet by Test Type
    • 2.1.2. Endocrine Function Diagnostics Market Snippet by Technology
    • 2.1.3. Endocrine Function Diagnostics Market Snippet by Application
    • 2.1.4. Endocrine Function Diagnostics Market Snippet by Country
    • 2.1.5. Endocrine Function Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Endocrine Function Diagnostics Key Market Trends

  • 3.1. Endocrine Function Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Endocrine Function Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Endocrine Function Diagnostics Market Opportunities
  • 3.4. Endocrine Function Diagnostics Market Future Trends

4. Endocrine Function Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Endocrine Function Diagnostics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Endocrine Function Diagnostics Market Landscape

  • 6.1. Endocrine Function Diagnostics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Endocrine Function Diagnostics Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2024&2032 (%)
    • 7.1.2. Thyroid Function Tests
    • 7.1.3. Diabetes Tests
    • 7.1.4. Adrenal Function Tests
    • 7.1.5. Reproductive Hormone Tests
    • 7.1.6. Others

8. Endocrine Function Diagnostics Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024&2032 (%)
    • 8.1.2. Immunoassays
    • 8.1.3. Tandem Mass Spectrometry (LC-MS/MS)
    • 8.1.4. Enzyme-linked Assays
    • 8.1.5. Others

9. Endocrine Function Diagnostics Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024&2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Diagnostic Laboratories
    • 9.1.4. Research Institutes
    • 9.1.5. Others

10. Endocrine Function Diagnostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Endocrine Function Diagnostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.2.7.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.8.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.2.8.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Endocrine Function Diagnostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.7.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.3.7.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.8.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.3.8.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.8.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.9.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.3.9.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.9.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.10.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.3.10.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.10.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.11.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.3.11.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.11.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.13.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.3.13.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.13.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.14.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.3.14.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.14.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.15.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.3.15.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.15.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Endocrine Function Diagnostics Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.7.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.4.7.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.7.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.8.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.4.8.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.9.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.4.9.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.4.10.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.11.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.4.11.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.12.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.13.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.4.13.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.14.3. PhilippinesMarket Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.4.14.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Endocrine Function Diagnostics Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.5.7.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.5.8.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.5.9.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.5.10.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Endocrine Function DiagnosticsKey Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.8.3. UAE Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.6.8.4. UAE Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.6.8.5. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.9.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.6.9.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.6.10.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.6.11.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.6.12.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)

11. Key Vendor Analysis- Endocrine Function Diagnostics Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
      • 11.2.1.1.
    • 11.2.2. Roche Diagnostics
    • 11.2.3. Siemens Healthineers
    • 11.2.4. Danaher Corporation
    • 11.2.5. Thermo Fisher Scientific
    • 11.2.6. bioMerieux
    • 11.2.7. Sysmex Corporation
    • 11.2.8. DiaSorin S.p.A.
    • 11.2.9. Mindray Medical International
    • 11.2.10. Ortho Clinical Diagnostics

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us